AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prevention of Opioid-induced Constipation in Patients With Advanced Cancer

RecruitingPhase 4Ages 18 Years - anyAllAmsterdam UMC, location VUmc
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

More than 70% of patients with cancer in the palliative phase have pain that often requires treatment with opioids (morphine-like agents). Constipation occurs in 59% of patients treated with opioids. Opioid-induced constipation (OIC) has consequences that range from daily discomfort with social insecurity and disability to intestinal obstruction. It leads to limitations in self-management, a reduced quality of life and a risk of the need for more care. In the guideline "Diagnosis and treatment of pain in patients with cancer" it is recommended to start preventively with an osmotic laxative such as macrogol/electrolytes or magnesium hydroxide when starting opioids. Macrogol/electrolytes has been proven to be effective for OIC, but is sometimes perceived by patients as unpleasant due to its taste. Magnesium hydroxide, which is less commonly prescribed for OIC, has a neutral taste. Although

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Patients with advanced cancer (โ‰ฅ18 years); * Starting with slow release or transdermal opioids for pain; * Able to complete a Dutch questionnaire. Previous treatment with opioids is allowed, if discontinued more than 4 weeks ago. Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Patients with contra-indications for laxatives * Maintenance treatment with laxatives during the last 14 days * Severely impaired renal function (serum creatinine \>180 umol/l) * Estimated life expectancy \<1 month
๐Ÿ’Š

What it tests

  • Macrogol Only Product in Oral Dose Form
  • Magnesium hydroxide 724mg
๐Ÿ“

Where

13 sites
Flevoziekenhuis
Almere Stad, Netherlands
Rijnstate Ziekenhuis
Arnhem, Netherlands
Radboud university Medical center Nijmegen
Nijmegen, Netherlands
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
Amsterdam UMC, location VUmc
Amsterdam, Netherlands
Spaarne Gasthuis
Hoofddorp, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Martini Hospital Groningen
Groningen, Netherlands

โ€ฆand 5 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy